DNA-WT NYSE
Ginkgo Bioworks Holdings, Inc. WT
1W: -4.7%
1M: -27.8%
3M: +17.6%
1Y: +79.7%
$0.27
Last traded 2025-03-10 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.1B
-18.7% ▼
5Y CAGR: +10.6%
Total Liabilities
$611M
-7.6% ▼
5Y CAGR: +24.4%
Shareholders Equity
$509M
-29.0% ▼
5Y CAGR: +2.0%
Cash & Investments
$423M
-24.7% ▼
5Y CAGR: +2.1%
Total Debt
$417M
-10.8% ▼
5Y CAGR: +89.6%
Net Debt
$250M
+366.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.6B | $1.3B | $944M | $562M | $167M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $255M |
| Cash & ST Investments | $1.6B | $1.3B | $944M | $562M | $423M |
| Net Receivables | $150M | $84M | $18M | $22M | $24M |
| Inventory | $3M | $4M | $46K | $0 | $0 |
| Other Current Assets | $698K | $9M | $19M | $19M | $25M |
| Total Current Assets | $1.7B | $1.5B | $1.0B | $603M | $472M |
| Property, Plant & Equip. | $146M | $719M | $395M | $598M | $529M |
| Goodwill & Intangibles | $43M | $171M | $132M | $73M | $57M |
| Long-Term Investments | $115M | $112M | $78M | $49M | $15M |
| Other Non-Current Assets | $44M | $87M | $59M | $55M | $47M |
| Total Non-Current Assets | $348M | $1.1B | $664M | $775M | $648M |
| Total Assets | $2.1B | $2.5B | $1.7B | $1.4B | $1.1B |
| — Liabilities — | |||||
| Accounts Payable | $8M | $10M | $9M | $14M | $11M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $33M | $48M | $48M | $31M | $19M |
| Other Current Liabilities | $40M | $53M | $54M | $27M | $66M |
| Total Current Liabilities | $135M | $173M | $164M | $107M | $96M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $417M |
| Other Non-Current Liab. | $191M | $42M | $24M | $17M | $98M |
| Total Non-Current Liabilities | $369M | $630M | $404M | $554M | $515M |
| Total Liabilities | $504M | $803M | $568M | $661M | $611M |
| — Equity — | |||||
| Common Stock | $161K | $190K | $5K | $5K | $6K |
| Retained Earnings | -$2.3B | -$4.4B | -$5.3B | -$5.8B | -$6.2B |
| Accumulated OCI | -$2M | -$3M | $1M | -$2M | $2M |
| Total Stockholders Equity | $1.5B | $1.7B | $1.1B | $716M | $509M |
| Total Liabilities & Equity | $2.1B | $2.5B | $1.7B | $1.4B | $1.1B |
| — Key Metrics — | |||||
| Total Debt | $23M | $443M | $239M | $468M | $417M |
| Net Debt | -$1.5B | -$873M | -$705M | -$94M | $250M |
| Total Investments | $115M | $112M | $78M | $49M | $270M |